Anti-angiogenic efficacy and mechanism of the low molecular weight heparin (LMWH), tinzaparin and tissue factor pathway inhibitor (TFPI): potential anti-cancer benefits - Mousa, SA; Mohamed, S (Thromb Haemost, 2001)
Suppl